Courtney Hanlon

发表

Phase I study of TH-302, an investigational hypoxia-targeted drug, and dexamethasone in patients with relapsed/refractory multiple myeloma.

J. Laubach, P. Richardson, P. Armand, 2013 .

Phase I/II Trial of Plerixafor and Bortezomib As a Chemosensitization Strategy In Relapsed Or Relapsed/Refractory Multiple Myeloma

N. Munshi, J. Laubach, P. Richardson, 2010 .